Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Efstathiou

Showing results (221-230 of 273) with videos related to

Pageof 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2023
Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder CancerSophia C Kamran, Yuzhen Zhou, Keisuke Otani, et al.
Urologic Oncology|July 29, 2014
Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forwardAndrea B Apolo, Vanessa Hoffman, Matthew G Kaag, et al.
European Urology Oncology|November 14, 2024
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 TrialsKrishnan R Patel, Paul L Nguyen, James A Proudfoot, et al.
Advances in Radiation Oncology|April 20, 2026
The Association of p27 With Prostate Cancer Outcomes: A Secondary Analysis of NRG/RTOG 8610 and 9202Krishnan R Patel, Stephanie L Pugh, Jeffry P Simko, et al.
JAMA Oncology|January 27, 2018
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological FeaturesWilliam L Hwang, Rahul D Tendulkar, Andrzej Niemierko, et al.
International Journal of Radiation Oncology, Biology, Physics|August 2, 2025
Long term results of NRG Oncology RTOG 9601, a randomized trial of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy post prostatectomyHimanshu R Lukka, Stephanie L Pugh, William U Shipley, et al.
Cell|June 16, 2023
DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCsHongshan Guo, Joanna A Vuille, Ben S Wittner, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2014
Addressing the growing cancer burden in the wake of the AIDS epidemic in Botswana: The BOTSOGO collaborative partnershipJason A Efstathiou, Memory Bvochora-Nsingo, David P Gierga, et al.
International Journal of Radiation Oncology, Biology, Physics|February 3, 2023
Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415Jinbing Bai, Stephanie L Pugh, Ronald Eldridge, et al.
Science Advances|November 22, 2023
ATM deficiency confers specific therapeutic vulnerabilities in bladder cancerYuzhen Zhou, Judit Börcsök, Elio Adib, et al.
Pageof 28

Showing results (221-230 of 273) with videos related to

Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2023
Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder CancerSophia C Kamran, Yuzhen Zhou, Keisuke Otani, et al.
Urologic Oncology|July 29, 2014
Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forwardAndrea B Apolo, Vanessa Hoffman, Matthew G Kaag, et al.
European Urology Oncology|November 14, 2024
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 TrialsKrishnan R Patel, Paul L Nguyen, James A Proudfoot, et al.
Advances in Radiation Oncology|April 20, 2026
The Association of p27 With Prostate Cancer Outcomes: A Secondary Analysis of NRG/RTOG 8610 and 9202Krishnan R Patel, Stephanie L Pugh, Jeffry P Simko, et al.
JAMA Oncology|January 27, 2018
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological FeaturesWilliam L Hwang, Rahul D Tendulkar, Andrzej Niemierko, et al.
International Journal of Radiation Oncology, Biology, Physics|August 2, 2025
Long term results of NRG Oncology RTOG 9601, a randomized trial of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy post prostatectomyHimanshu R Lukka, Stephanie L Pugh, William U Shipley, et al.
Cell|June 16, 2023
DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCsHongshan Guo, Joanna A Vuille, Ben S Wittner, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2014
Addressing the growing cancer burden in the wake of the AIDS epidemic in Botswana: The BOTSOGO collaborative partnershipJason A Efstathiou, Memory Bvochora-Nsingo, David P Gierga, et al.
International Journal of Radiation Oncology, Biology, Physics|February 3, 2023
Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415Jinbing Bai, Stephanie L Pugh, Ronald Eldridge, et al.
Science Advances|November 22, 2023
ATM deficiency confers specific therapeutic vulnerabilities in bladder cancerYuzhen Zhou, Judit Börcsök, Elio Adib, et al.
Pageof 28